Takahashi Shinichiro

論文

Neoadjuvant S-1 With Concurrent Radiotherapy Followed by Surgery for Borderline Resectable Pancreatic Cancer

ASO Author Reflections: Circulating Tumor DNA (ctDNA) as a Potentially Practice-Changing Innovation to Evolve “Precision Onco-Surgery” in Resectable Colorectal Liver Metastases

Impact of Preoperative Circulating Tumor DNA Status on Survival Outcomes After Hepatectomy for Resectable Colorectal Liver Metastases

Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer.

Objective assessment of tumor regression in post-neoadjuvant therapy resections for pancreatic ductal adenocarcinoma: comparison of multiple tumor regression grading systems

Survival Outcomes of Resected BRAF V600E Mutant Colorectal Liver Metastases: A Multicenter Retrospective Cohort Study in Japan.

ASO Author Reflections: The Moment That BRAF V600E Mutation Starts Evolving into "Precision Oncosurgery" in Colorectal Liver Metastases.

Area of residual tumor (ART) can predict prognosis after post neoadjuvant therapy resection for pancreatic ductal adenocarcinoma.

How to treat borderline resectable pancreatic cancer: current challenges and future directions.

Neoadjuvant S-1 with concurrent radiotherapy followed by surgery for borderline resectable pancreatic cancer: study protocol for an open-label, multicentre, prospective phase II trial (JASPAC05).

Pancreas-preserving resection of lower biliary tract adenocarcinoma: A coring-out technique.

In Patients with a Soft Pancreas, a Thick Parenchyma, a Small Duct, and Fatty Infiltration Are Significant Risks for Pancreatic Fistula After Pancreaticoduodenectomy.

Measure of pancreas transection and postoperative pancreatic fistula.

Pancreatic perfusion data and post-pancreaticoduodenectomy outcomes.

What is the nature of pancreatic consistency? Assessment of the elastic modulus of the pancreas and comparison with tactile sensation, histology, and occurrence of postoperative pancreatic fistula after pancreaticoduodenectomy.

Schematic pancreatic configuration: a risk assessment for postoperative pancreatic fistula after pancreaticoduodenectomy.

Efficacy of the predicted operation time (POT) strategy for synchronous colorectal liver metastasis (SCLM): feasibility study for staged resection in patients with a long POT.

Predictors for early recurrence after hepatectomy for initially unresectable colorectal liver metastasis.

Predictive factors for anastomotic leakage after simultaneous resection of synchronous colorectal liver metastasis.

Borderline resectable pancreatic cancer: rationale for multidisciplinary treatment.

Factors predicting survival in advanced T-staged hepatocellular carcinoma patients treated with reduction hepatectomy followed by transcatheter arterial chemoembolization.

Multiple resections for hepatic and pulmonary metastases of colorectal carcinoma.

Positron emission tomography with F-18 fluorodeoxyglucose in evaluating colorectal hepatic metastasis down-staged by chemotherapy.

Importance of intra-individual variation in tumour volume of hepatic colorectal metastases.

Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis.

Prognostic factors for poor survival after repeat hepatectomy in patients with colorectal liver metastases.

Cytoplasmic expression of laminin gamma2 chain correlates with postoperative hepatic metastasis and poor prognosis in patients with pancreatic ductal adenocarcinoma.

Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancer.

共同研究・競争的資金等の研究課題

An investigator-initiated phase II trial of precision perioperative systemic therapy for BRAF V600E-mutated metastatic colorectal cancer

Multicenter randomized controlled trial designed to establish the standard therapy for the borderline resectable pancreatic cancer

Program on the site development for the creation of innovative medical devices in total cancer care.

Study on building a research structure to incubate and enhance an early phase clinical trial in perioperative treatment (30-A-8).

Study on establishment of the standard therapy for the borderline resectable pancreatic cancer

Study on establishment of the multidisciplinary treatment for the borderline resectable pancreatic cancer